2019
DOI: 10.1152/ajprenal.00163.2018
|View full text |Cite
|
Sign up to set email alerts
|

The determinants, biomarkers, and consequences of microvascular injury in kidney transplant recipients

Abstract: Independent of the initial cause of kidney disease, microvascular injury to the peritubular capillary network appears to play a central role in the development of interstitial fibrosis in both native and transplanted kidney disease. This association is explained by mechanisms such as the upregulation of profibrotic genes and epigenetic changes induced by hypoxia, capillary leakage, endothelial and pericyte transition to interstitial fibroblasts, as well as modifications in the secretome of endothelial cells. A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 133 publications
1
12
0
Order By: Relevance
“…These results are in line with a predominant role for endothelial injury in the pathophysiology of AMR. 2 It is likely, although not specifically tested in this publication, that EVs found in AMR patients are derived from injured or dying endothelial cells from the kidney microvasculature. Indeed, antibody-mediated endothelial injury is one of the main etiologies of microvascular damage in kidney transplant recipients.…”
Section: E D I T O R I a L Extracellular Vesicles Beyond Biomarkers: ...mentioning
confidence: 91%
See 1 more Smart Citation
“…These results are in line with a predominant role for endothelial injury in the pathophysiology of AMR. 2 It is likely, although not specifically tested in this publication, that EVs found in AMR patients are derived from injured or dying endothelial cells from the kidney microvasculature. Indeed, antibody-mediated endothelial injury is one of the main etiologies of microvascular damage in kidney transplant recipients.…”
Section: E D I T O R I a L Extracellular Vesicles Beyond Biomarkers: ...mentioning
confidence: 91%
“…It is likely, although not specifically tested in this publication, that EVs found in AMR patients are derived from injured or dying endothelial cells from the kidney microvasculature. Indeed, antibody‐mediated endothelial injury is one of the main etiologies of microvascular damage in kidney transplant recipients 2 . The presence of donor‐specific anti‐human leukocyte antigen (HLA) antibodies or non‐HLA autoantibodies have been implicated in in complement activation with diffuse C4d staining in peritubular capillaries, leading to endothelial stress and death and peritubular capillaritis.…”
mentioning
confidence: 99%
“…3-6 In particular, microvascular inflammation, whether meeting criteria for antibody-mediated rejection or not, is an important cause of allograft damage, 7-11 that can cause capillary leak, tissue edema, and consequent organ stiffening. 12-14…”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5][6] In particular, microvascular inflammation, whether meeting criteria for antibodymediated rejection or not, is an important cause of allograft damage, [7][8][9][10][11] that can cause capillary leak, tissue edema, and consequent organ stiffening. [12][13][14] Magnetic resonance elastography (MRE) is a functional MRI technique that can be used to image organ stiffness. 15 In this technique, an oscillatory pressure source transmits small vibrations through the allograft, whereas synchronized MRI images are used to measure the induced microscopic tissue motion.…”
Section: Introductionmentioning
confidence: 99%
“…Microvascular injury and associated tissue remodeling during acute rejection are caused by a massive microvascular infiltration of CD4 + T cells and antibody-mediated complement activation on vascular endothelial cells [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 ], and there are no ongoing immunosuppressive regimens that sufficiently preserve functional microvasculature [ 3 , 9 , 10 ]. This leads to the progression of chronic lung rejection/bronchiolitis obliterans syndrome (BOS) as seen in clinical settings [ 7 , 11 ].…”
Section: Introductionmentioning
confidence: 99%